17-63872128-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM4BP6_Very_StrongBS2
The NM_020991.4(CSH2):āc.652T>Cā(p.Ter218GlnextTer?) variant causes a stop lost change. The variant allele was found at a frequency of 0.00425 in 1,614,102 control chromosomes in the GnomAD database, including 70 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0030 ( 3 hom., cov: 29)
Exomes š: 0.0044 ( 67 hom. )
Consequence
CSH2
NM_020991.4 stop_lost
NM_020991.4 stop_lost
Scores
2
1
4
Clinical Significance
Conservation
PhyloP100: 6.01
Genes affected
CSH2 (HGNC:2441): (chorionic somatomammotropin hormone 2) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones and plays an important role in growth control. The gene is located at the growth hormone locus on chromosome 17 along with four other related genes in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. Although the five genes share a remarkably high degree of sequence identity, they are expressed selectively in different tissues. Alternative splicing generates additional isoforms of each of the five growth hormones. This particular family member is expressed mainly in the placenta and utilizes multiple transcription initiation sites. Expression of the identical mature proteins for chorionic somatomammotropin hormones 1 and 2 is upregulated during development, while the ratio of 1 to 2 increases by term. Structural and expression differences provide avenues for developmental regulation and tissue specificity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PM4
Stoplost variant in NM_020991.4 Downstream stopcodon found after 65 codons.
BP6
Variant 17-63872128-A-G is Benign according to our data. Variant chr17-63872128-A-G is described in ClinVar as [Benign]. Clinvar id is 717494.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSH2 | NM_020991.4 | c.652T>C | p.Ter218GlnextTer? | stop_lost | 5/5 | ENST00000392886.7 | NP_066271.1 | |
CSH2 | NM_022645.2 | c.367T>C | p.Ter123GlnextTer? | stop_lost | 3/3 | NP_072171.1 | ||
CSH2 | NM_022644.3 | c.*401T>C | 3_prime_UTR_variant | 4/4 | NP_072170.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSH2 | ENST00000392886.7 | c.652T>C | p.Ter218GlnextTer? | stop_lost | 5/5 | 1 | NM_020991.4 | ENSP00000376623 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00301 AC: 458AN: 152166Hom.: 3 Cov.: 29
GnomAD3 genomes
AF:
AC:
458
AN:
152166
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00358 AC: 901AN: 251390Hom.: 10 AF XY: 0.00339 AC XY: 460AN XY: 135870
GnomAD3 exomes
AF:
AC:
901
AN:
251390
Hom.:
AF XY:
AC XY:
460
AN XY:
135870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00438 AC: 6401AN: 1461818Hom.: 67 Cov.: 31 AF XY: 0.00419 AC XY: 3047AN XY: 727214
GnomAD4 exome
AF:
AC:
6401
AN:
1461818
Hom.:
Cov.:
31
AF XY:
AC XY:
3047
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00301 AC: 458AN: 152284Hom.: 3 Cov.: 29 AF XY: 0.00313 AC XY: 233AN XY: 74464
GnomAD4 genome
AF:
AC:
458
AN:
152284
Hom.:
Cov.:
29
AF XY:
AC XY:
233
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
20
ALSPAC
AF:
AC:
21
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
43
ExAC
AF:
AC:
447
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
D;N;N;N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at